← Eichor
Study identifier: NCT06733077 Synced from ClinicalTrials.gov · July 28, 2026
● Recruiting

Development of Digital Services for Parkinson's Disease

Condition: Healthy Controls · Parkinson's Disease  ·  Sponsor: University of Exeter

PhaseNA
Planned participants80
Who can joinAll sexes, 18 Years to no upper limit
Healthy volunteersYes

About this study

In this project, ocular motor, pupil and gait data in people with Parkinson's disease (PD) will be collected in order to develop machine learning models for the diagnosis and monitoring of PD. With this, the investigators aim to advance the state of the art in PD diagnosis and monitoring. By integrating the principles of machine learning with high-quality sensor data, more accurate and earlier diagnosis could potentially be achieved. Ocular motor and pupil data will be collected with the standard clinical examination and with neos, a medical device approved for objective ocular motor and pupil measurement. Gait will be collected using an IMU sensor and GaitQ senti, a consumer device that allows for an objective and continuous remote gait monitoring.

This description comes directly from the study's public registry record.

Talk to the study team

Pavlos Evangelidis, PhD  ·  00447866138722  ·  p.evangelidis@exeter.ac.uk

Helen Dawes, PhD  ·  01392 40 2969  ·  H.Dawes@exeter.ac.uk

Always discuss trial participation with your own doctor first.

Locations (1)

University of ExeterExeter, United KingdomRecruiting

Follow this study

Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.

We email about this public record only. Unsubscribe anytime with one click. Never medical advice.

Is this your study? This page was generated automatically from the public registry record. Sponsors can claim it — free — to add branding and verified contact routing. Claim this page →

This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.

Source record: clinicaltrials.gov/study/NCT06733077